Comgest Global Investors S.A.S. Cuts Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Comgest Global Investors S.A.S. trimmed its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 24.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,400 shares of the medical equipment provider's stock after selling 4,906 shares during the quarter. Comgest Global Investors S.A.S.'s holdings in Intuitive Surgical were worth $8,038,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the company. CreativeOne Wealth LLC raised its holdings in Intuitive Surgical by 87.8% during the fourth quarter. CreativeOne Wealth LLC now owns 4,986 shares of the medical equipment provider's stock valued at $2,602,000 after acquiring an additional 2,331 shares during the period. Mariner LLC grew its holdings in Intuitive Surgical by 5.1% during the 4th quarter. Mariner LLC now owns 89,122 shares of the medical equipment provider's stock valued at $46,520,000 after buying an additional 4,327 shares in the last quarter. Peninsula Wealth LLC purchased a new position in shares of Intuitive Surgical in the fourth quarter worth $227,000. Giverny Capital Inc. bought a new stake in Intuitive Surgical in the 4th quarter valued at $211,000. Finally, SageView Advisory Group LLC grew its holdings in Intuitive Surgical by 23.0% during the 4th quarter. SageView Advisory Group LLC now owns 3,496 shares of the medical equipment provider's stock worth $1,825,000 after acquiring an additional 653 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have issued reports on ISRG. Erste Group Bank lowered shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Monday, March 17th. Piper Sandler restated an "overweight" rating and issued a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Barclays raised their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Leerink Partners boosted their price objective on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Finally, JPMorgan Chase & Co. boosted their price target on Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $611.81.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now owns 5,224 shares in the company, valued at $2,607,925.28. The trade was a 68.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Jamie Samath sold 94 shares of the stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the transaction, the chief financial officer now owns 2,630 shares of the company's stock, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 33,754 shares of company stock valued at $17,691,621. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Trading Up 0.3 %

NASDAQ ISRG traded up $1.40 on Friday, reaching $482.74. 1,618,989 shares of the company were exchanged, compared to its average volume of 1,599,026. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The stock has a market capitalization of $171.94 billion, a P/E ratio of 75.31, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55. The business's fifty day moving average price is $522.23 and its 200 day moving average price is $532.02.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.